3-56 Docetaxel, Cisplatin, and Trastuzumab As Primary Systemic Therapy for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced Breast Cancer

A. U. Buzdar

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of '3-56 Docetaxel, Cisplatin, and Trastuzumab As Primary Systemic Therapy for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced Breast Cancer'. Together they form a unique fingerprint.